STAT1 Gain-of-Function and Hidradenitis Suppurativa Successfully Managed with Baricitinib

J Clin Immunol. 2023 Jul;43(5):898-901. doi: 10.1007/s10875-023-01454-2. Epub 2023 Mar 7.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Azetidines* / therapeutic use
  • Gain of Function Mutation
  • Hidradenitis Suppurativa* / diagnosis
  • Hidradenitis Suppurativa* / drug therapy
  • Humans
  • Purines / therapeutic use
  • STAT1 Transcription Factor

Substances

  • baricitinib
  • Azetidines
  • Purines
  • STAT1 protein, human
  • STAT1 Transcription Factor